Tuesday, 9 July 2013

Phase II trial of new treatment for MS shows promising results

Source: MS Research Australia

The results of a Phase II clinical trial looking at the effects of a new therapy for relapsing remitting MS, siponimod, has been published this week in the journal Lancet Neurology.  Read more here